Then you have studies that have completely different results - as this is a very heterogenous disease.
It's extremely hard to draw conclusions without proper controls.
The FDA understands this. Why do you think they asked twice for an RCT?
Then you have studies that have completely different results -...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.020(1.70%) |
Mkt cap ! $1.318B | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.21 | $1.14 | $7.882M | 6.770M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 115926 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 36275 | 6 |
View Market Depth
| Last trade - 14.45pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.16 |
Change
-0.020 ( 1.47 %) |
||||
| Open | High | Low | Volume | ||
| $1.21 | $1.21 | $1.14 | 966121 | ||
| Last updated 14.57pm 27/05/2024 ? | |||||
| MSB (ASX) Chart |